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Background: Despite Cryptostegia grandiflora Roxb. ex R. Br. (Apocynaceae) leaves are widely used in folk Caribbean
Colombian medicine for their anti-inflammatory effects, there are no studies that support this traditional use. Therefore,
this work aimed to evaluate the effect of the total extract and primary fractions obtained from Cryptostegia grandiflora
leaves, using in vivo and in vitro models of inflammation, and further get new insights on the mechanisms involved in
this activity.
Results: Ethanolic extract of Cryptostegia grandiflora leaves, and its corresponding ether and dichloromethane
fractions, significantly reduced inflammation and myeloperoxidase activity (MPO) in ear tissue of mice treated with
12-O-tetradecanoyl-phorbol-13-acetate (TPA). Histological analysis revealed a reduction of edema and leukocyte
infiltration. Complementarily, we demonstrated that extract and fractions reduced nitric oxide (NO•) and prostaglandin
E2 (PGE2) production in LPS-stimulated RAW 264.7 macrophages, as well as scavenging activity on DPPH and
ABTS radicals.
Conclusions: Our results demonstrated for the first time the anti-inflammatory activity of Cryptostegia grandiflora
leaves, supporting its traditional use. This activity was related to inhibition of MPO activity, and PGE2 and NO• production.
These mechanisms and its antioxidant activity could contribute, at least in part, to the anti-inflammatory effect showed
by this plant.
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Harmful stimuli to body, such as pathogens, damaged
cells or physical injury, are able to trigger an inflamma-
tory response. When this response is persistent, chronic
inflammation appears as an undesirable phenomenon
that can lead to the development of severe diseases such
as osteoarthritis, rheumatoid arthritis, gout, asthma,
inflammatory bowel disease, diabetes, cancer, cardiovas-
cular disease and neurodegenerative disorders, which
represent an important cause of morbidity and mortality
worldwide [1-3].
Macrophages are considered the main immune ef-
fector cells, playing a pivotal role in tissue damage in
a great number of inflammatory conditions, both
acute and chronic. Activated macrophages are able to
synthesize reactive oxygen species (radical superoxide •O2
−,* Correspondence: lfrancoo@unicartagena.edu.co
Biological Evaluation of Promissory Substances Group, Faculty of
Pharmaceutical Sciences, University of Cartagena, Cartagena 130015,
Colombia
© 2014 Castro et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.hydrogen peroxide H2O2, and the highly reactive hydroxyl
radical •OH), NO•, arachidonic acid metabolites, and lyso-
somal enzymes which are necessary to perform their
phagocytic function. These cells also play an important role
in the development of various chronic diseases such as
cancer and allergies [4-6].
Traditional medicine has been a revealing source of
new molecules in modern drug discovery, thus the use
of herbal medicines or their active components repre-
sents an increasingly explored and promissory alterna-
tive for the treatment of numerous diseases, including
inflammatory disorders [7]. The application of natural
products in traditional medical systems of many coun-
tries is due to a current trend towards the use of green
products because they are considered safer. However,
limited scientific evidence regarding to the effectiveness
of natural bioactive derivatives, in addition to a limited
understanding of the mechanisms of action related with
their biological activity, has limited its incorporation into
clinical practice [8-10].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Topical anti-inflammatory effect of the total








Control (TPA + acetone) ——— 13.5 ± 0.6 ———
Indomethacin 0.5 7.4 ± 0.8 52.4 ± 6.2***
Cryptostegia grandiflora
Total extract 1.0 7.6 ± 0.1 42.1 ± 0.9***
Ether fraction 1.0 8.1 ± 0.8 41.8 ± 8.0***
Dichloromethane
fraction
1.0 6.1 ± 0.5 52.9 ± 4.3***
Methanol fraction 1.0 12.2 ± 0.4 6.8 ± 3.2
Results are expressed as mean ± S.M.E. (n = 6) (***p <0.001 ANOVA, statistically
significant compared with control group).
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http://www.biolres.com/content/47/1/32Considering the folk use of Cryptostegia grandiflora
Roxb. ex R. Br. (Apocynaceae) on inflammatory condi-
tions, which was revealed by ethnobotanical studies con-
ducted by research groups at the University of Cartagena
in the Colombian Caribbean region, and that no infor-
mation is available about its topical anti-inflammatory
properties, we investigated the effect of the total etha-
nolic extract and primary fractions obtained from the
leaves of this plant using a murine model of topical
inflammation. Additionally to further get new insights
into the possible mechanisms involved in this activity,
we evaluated the effect on PGE2 and NO• production,




Cryptostegia grandiflora also known in Colombian
Caribbean coast as “20 de Julio or Flor de Muerto” and
rubber vine in English speaking countries, is a perennial
woody shrub widely distributed in Madagascar, India,
South Florida and tropical regions [11-13]. Due to its
high latex content, Cryptostegia grandiflora is employed
in the manufacture of rubber and as a source of hydro-
carbon fuels [11]. However, the interest in this plant is
not restricted to its industrial applications, but rather
to its usages in folk medicine as hypoglycemic, coagulant,
antibacterial, anti-inflammatory, anti-asthmatic and for
the treatment of nervous disorders [13-17], representing
a promissory source of bioactive secondary metabolites.
Consequently, several research groups have corrobo-
rated many of the biological activities mentioned above.
However, to our knowledge, this is the first report of
the anti-inflammatory activity of Cryptostegia grandiflora
leaves.
TPA-induced ear edema model is a valid model to ef-
fectively screen compounds with anti-inflammatory poten-
tial. Topical application of TPA induces an inflammatory
response associated with edema formation and increased
MPO activity [18-20]. This is consistent with the results
obtained in our study, where topical application of TPA
induced a severe inflammatory response in mouse ear that
resulted in massive edema formation which was evident
by the increased ear weight in comparison with control
group, only treated with acetone (p < 0.001). Total extract
and ether and dichloromethane fractions from Cryptos-
tegia grandiflora significantly reduced inflammation in-
duced by TPA, with inhibition percentages higher than
40%, similar to that produced by indomethacin, which
was used as positive control, whereas methanol fraction
did not exert anti-inflammatory effects (Table 1). None
of the tested extract/fractions produced evident adverse
local or systemic effects, suggesting that their topical ad-
ministration is well tolerated. Due to the lack of bioactivityof methanol fraction in the in vivo model, we selected
the total extract and ether and dichloromethane frac-
tions of Cryptostegia grandiflora to further evaluate
their histopathological effect and the inhibition of MPO
activity.
TPA promoted a marked increase in ear thickness,
with clear evidence of edema, substantial neutrophil infil-
tration, and hyperplasia and hypertrophy of dermis and
epidermis (Figure 1B). Treatment with Cryptostegia gran-
diflora total extract (Figure 1D) and ether (Figure 1E) and
dichloromethane fractions (Figure 1F) notably reduced
the total score, established by a blinded pathologist,
over 45%.
MPO activity
TPA treatment induced an increase in the tissue MPO
activity. Ether and dichloromethane fractions from Cryp-
tostegia grandiflora have a significant inhibitory effect on
the activity of this enzyme by over 96%, showing higher
activity than the positive control indomethacin (Table 2),
which showed inhibition of 77.7 ± 2.2%.
Treatment with total extract of Cryptostegia grandi-
flora leaves reduced inflammation and MPO activity in
ear tissue. Such bioactivity is kept in its ether and di-
chloromethane fractions, which have different polarity,
suggesting the presence of structurally diverse phyto-
constituents that might be exerting its activity by dif-
ferent molecular mechanisms, contributing additively
to the global anti-inflammatory effect. These results are
very promissory since tested fractions constitute a mix-
ture of many secondary metabolites, providing the first
step of a bio-guided isolation conducted to isolate com-
pounds with higher anti-inflammatory activity. Com-
plementarily, our results suggests the usefulness of
Cryptostegia grandiflora extracts and primary fractions
to treat inflammatory skin diseases, including psoria-
sis and atopic dermatitis, without exerting signals of
Figure 1 Histopathological changes produced by total extract and primary fractions of Cryptostegia grandiflora, qualified by a blinded
pathologist. Pictures represents sections from mice ears stained with hematoxylin and eosin (40X) from: (A) Healthy group, (B) Control group
(TPA, 2.5 μg/ear), (C) TPA and Indomethacin (0.5 mg/ear), (D) TPA and Cryptostegia grandiflora total extract (1.0 mg/ear), (E) TPA and Cryptostegia
grandiflora ether fraction (1.0 mg/ear), and (F) TPA and Cryptostegia grandiflora dichloromethane fraction (1.0 mg/ear). The numbers 1 and 2
indicate epidermis and dermis, respectively. Arrows indicate cell infiltration into the dermis.
Table 2 Effect of total extract and primary fractions
obtained from Cryptostegia grandiflora leaves on MPO







Control (TPA + acetone) ——— 18150 ± 2012.3 —
Indomethacin 0.5 4040 ± 406.9 77.7 ± 2.2***
Cryptostegia grandiflora
Total extract 1.0 11040 ± 987.8 39.1 ± 5.4***
Ether fraction 1.0 600 ± 89.4 96.6 ± 0.4***
Dichloromethane fraction 1.0 666 ± 98.8 96.3 ± 0.5***
Results are expressed as mean ± S.M.E. (n = 6) (***p < 0.001 ANOVA, statistically
significant compared with control group).
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http://www.biolres.com/content/47/1/32systemic toxicity. However, a detailed study of toxicity
and dermal absorption will warrant its safety use as
phytotherapy.
Overall, the anti-inflammatory effect of ether and
dichloromethane fractions of Cryptostegia grandiflora is
similar or higher to that observed for indomethacin,
anti-inflammatory drug used as a reference [21,22]. There-
fore, these promissory fractions were selected to evaluate
their effect on NO and PGE2 production by LPS-induced
macrophages RAW 264.7 and their scavenging effect
of DPPH, ABTS and NO radicals, in order to get further
insights into the mechanisms related with the anti-
inflammatory activity.
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macrophages viability
Macrophages activation with LPS induces the produc-
tion of NO• and PGE2, two potent pro-inflammatory
mediators [23]. NO• acts as signaling molecule that pro-
motes growth and activity of immune cells [24]. Mean-
while, PGE2 induces arteriolar vasodilatation, increasing
of vascular permeability and corporal temperature, and
the pain produced by bradykinin, and serotonin [25]. In
this sense, reducing the production of these inflamma-
tory mediators is considered an alternative to prevent or
treat complications associated with diseases related with
inflammatory processes.
To guarantee that test fractions do not cause cell
death, we assessed their effect on cell viability employing
MTT assay. As can be seen in Figure 2, cell viability for
all tested concentrations of Cryptostegia grandiflora frac-
tions was similar to that obtained for control group (not
treated cells), with viability percentages over 95%. In this
way, concentrations below 75 μg/mL can be securely
evaluated using macrophages RAW 264.7.
Inhibitory activity of Cryptostegia grandiflora on NO• and
PGE2 production induced by LPS
Treatment with LPS to RAW 264.7 macrophages in-
duced synthesis and release of NO• and PGE2. Upon ex-
posure to LPS, macrophages increased nitrite production,
of up to 21.9 ± 0.7 μM, whereas cells in resting state re-
leased trace amounts of NO•. 1400 W, a selective inhibitor
of inducible nitric oxide synthase (iNOS), caused a de-
crease in LPS-induced NO• production by more than 70%
at 10 μM.
Ether and dichloromethane fractions from Cryptos-
tegia grandiflora diminished the production of NO• in
a concentration-dependent manner, reducing signifi-
cantly nitrite concentration in culture medium com-
pared to the group treated with LPS alone (Figure 3A
and 3B). On the other hand, ether and dichlorometh-
ane fractions did not show scavenging effects on NO•
free radical (data not shown), therefore the reduction
of nitrite concentration can be attributed directly to a
blockade in NO• production in LPS-induced RAW 264.7
macrophages.Figure 2 Effect of (A) ether and (B) dichloromethane fractions obtaine
macrophages. Cytotoxicity was measured with MTT assay. Each value represeMacrophages RAW 264.7, in resting state, released
44.2 ± 11.3 pg/mL of PGE2 during 24 h of incubation.
However, upon exposure to LPS alone, the macrophages
increased PGE2 production, of up to 3532.3 ± 32.1 pg/mL
(80 fold increase). Levels of LPS-induced PGE2 were
decreased by ether and dichloromethane fractions of
Cryptostegia grandiflora (75 μg/mL) to 1583.5 ± 15.9 and
1980.6 ± 143.4 pg/mL, respectively. In general, ether frac-
tion was more potent than dichloromethane, diminishing
levels of PGE2 in a dose dependent-manner, correspond-
ing to a 59.6% at 75 μg/mL, 49.2% at 50 μg/mL, and
44.8% at 25 μg/mL, whereas dichloromethane fraction
was only active at the highest test concentration produ-
cing 56.1% of inhibition (Figure 3C and 3D).
The above date demonstrated that ether and dichloro-
methane fractions from Cryptostegia grandiflora leaves
decreased the production of NO• and PGE2. This in-
hibitory effect might be contributing significantly to
the mechanism of the in vivo anti-inflammatory effect of
tested fractions.
Anti-oxidant activity
Cryptostegia grandiflora fractions, showed a potent scav-
enging effect of DPPH and ABTS free radicals, in a
concentration-dependent manner, with IC50 values lower
than 550 and 101 μg/mL, respectively (Table 3). Even
though these fractions did not present comparable activ-
ity to that presented by ascorbic acid, used as reference
control; they constitute a promissory source to isolate
bioactive compounds with antioxidant properties, as these
complex fractions are constituted by an elevated number
of compounds.
Considering that inflammatory processes, especially
those which are presented chronically, are associated
with an overproduction of free radicals that induce oxi-
dative stress and cause the onset of various degenerative
diseases [9,26], and the potent scavenging effect of
DPPH and ABTS free radicals exerted by ether and di-
chloromethane fractions of Cryptostegia grandiflora, we
consider that the important antioxidant activity of this
plant might be a key contributing factor to the reduction
of edema in animals treated with TPA. Analgesic activity
of a methanolic extract of leaves of Cryptostegiad from Cryptostegia grandiflora on cell viability of RAW 264.7
nts mean ± S.E.M. (n= 15). ***p < 0.001, compared with control group.
Figure 3 Inhibitory effect on NO• and PGE2 production by ether (A and C) and dichloromethane (B and D) fractions from Cryptostegia
grandiflora on RAW 264.7 cells stimulated with LPS (10 μg/mL) for 24 h. 1400 W (10 μM) and Rofecoxib (10 μM) were employed as positive
controls. Nitrite concentration in the culture medium was measured with the Griess reagent. PGE2 production was determined using a competitive
ELISA kit (R&D Systems, USA). Experiments were carried out in triplicate and results show the mean ± S.E.M. (n = 12). **p < 0.01, ***p < 0.001, compared
with LPS treated group.
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nificant pain reduction to the presence of flavonoids,
alkaloids, tannins, saponins, terpenoids and phenolic
compounds, especially to flavonoids and alkaloids
analgesic principles acting against PG pathway and
oxidative stress [27]. Considering that flavonoids has
been described as anti-inflammatory compounds with
several mechanism explaining their effect, including
antioxidant and radical scavenging activities and
modulation of the activities of arachidonic acid me-
tabolism enzymes (phospholipase A2, cyclooxygenase
and lipooxygenase) and nitric oxide synthase, their
presence in leaves extracts of Cryptostegia grandi-
flora can be directly related to the anti-inflammatory
activity demonstrated by us [28].Table 3 Antioxidant activity of ether and dichloromethane
fractions from Cryptostegia grandiflora leaves
DPPH IC50 (μg/mL) Confidence intervals
(μg/mL)
Ascorbic acid 10.9 (10.2-11.8)
Ether fraction 549.2 (505.3-593.5)
Dichloromethane fraction 485.9 (440.9-531.0)
ABTS
Ascorbic acid 2.3 (2.1-2.4)
Ether fraction 101.0 (92.7-109.2)
Dichloromethane fraction 96.9 (80.9-112.2)
Results are expressed as mean ± S.M.E. (n = 9).Conversely, the soluble protein fraction from the whole
latex of Cryptostegia grandiflora has been described to
induce a consistent inflammatory activity in different ex-
perimental models in vivo, regardless the administration
route [12]. In this respect the latex of Cryptostegia gran-
diflora appears to be different from that of Calotropis
procera Ait, R.Br (Apocynaceae), which produces both
pro-inflammatory and anti-inflammatory effects depend-
ing on the protein content and administration route [29].
Our results, might suggest that latex contains different
classes of proteins and secondary metabolites with con-
trasting bioactivities, providing a plentiful field for new
research.
In conclusion, further work is needed in order to identify
the specific antioxidant and anti-inflammatory compounds,
as well as to clarify the potential synergic effects that might
help to explain the mechanism of Cryptostegia grandiflora
extract and fractions.Conclusions
Our study demonstrated the anti-inflammatory activ-
ity of the extract and primary fractions obtained from
the leaves of Cryptostegia grandiflora, which appears
to be the first report establishing this biological activ-
ity and supporting the folk use of this plant in the
Colombian Caribbean region. The promissory results
obtained in this work constitutes the basis for further
studies aiming to isolate, purify and characterize the bio-
active anti-inflammatory compounds from Cryptostegia
Castro et al. Biological Research 2014, 47:32 Page 6 of 8





acin, 2,2-diphenyl-1-picrylhydrazyl (DPPH), ascorbic
acid, 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS), potassium persulfate (K2S2O8), Dulbecco’s Modi-
fied Eagle Medium (DMEM), L-glutamine, antibiotics
(Penicillin-Streptomycin), dimethyl sulfoxide (DMSO),
trypan blue, lipopolysaccharides from Escherichia coli
serotype 0127:B8 (LPS), (N-[[3-(aminomethyl)phenyl]
methyl]-ethanimidamide dihydrochloride (1400 W), rofe-
coxib, sodium nitrite (NaNO2), sodium nitroprusside
(SNP), N-(1,1-naphthyl)ethylenediamine dihydrochloride,
sulfanilamide, Phosphate Buffer Saline (PBS) tablets,
O-Dianisidine, ethylenediaminetetraacetic acid (EDTA),
hematoxylin and eosin were purchased from Sigma-
Aldrich (St. Louis, MO, USA). fetal bovine serum (FBS)
was obtained from GIBCO (Gaithersburg, MD, USA).
Hydrogen peroxide (H2O2), hexadecyl-trimethylammonium
bromide (HETAB), and 3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl-tertazolium bromide (MTT) from Calbiochem®
(San Diego, CA, USA). Organic solvents were analytical
grade and obtained from Mallinckrodt Baker (San Diego,
CA, USA).
Plant material
Leaves of Cryptostegia grandiflora (Apocynaceae) were
collected at Pueblo Nuevo, Bolivar, Colombia (4° 10° 44’
33” N; 75° 15’ 28” W; elevation 3 m.a.s.l.), in March 2011.
The plant material was identified by Felipe A. Cardona N.,
and the voucher specimen has been deposited with the
identification number HUA-175330 at the Herbarium
University of Antioquia, Medellin, Colombia.
Preparation of ethanol extract and primary fractions
Dried and powdered leaves (689.9 g) were exhaustively
extracted with ethanol by maceration at room temperature
(25 ± 3°C). The extract was then filtered and concentrated
in a rotary evaporator under controlled temperature (35–
45°C) and reduced pressure. A portion of the concentrated
total extract (10 g) was fractioned using liquid/liquid parti-
tion procedures with ether (1.4 g), dichloromethane (1.5 g),
and methanol (3.8 g).
Experimental animals
Female ICR mice weighing 20–25 g were provided by
Instituto Nacional de Salud, Colombia. Animals were
allowed to acclimatize for 10 days before use and fed with
standard rodent food and water ad libitum. They were
housed in filtered-capped polycarbonate cages and kept in
a controlled environment with temperature at 22 ± 3°Cand relative humidity between 65 to 75%, under a cycle
of 12 h light/darkness. All the procedures were per-
formed in accordance with ethical guidelines on the
care and use of animals in laboratory research, which
were approved by the Ethics Committee of the University
of Cartagena.
TPA-induced acute ear edema
The edema was induced by topical application of TPA
(2.5 μg/ear) in acetone, according to the method de-
scribed by De Young et al. [30]. Mice in groups (n = 6)
were treated on the inner and outer surfaces of the right
ear with an acetone solution containing test extracts/
fractions from Cryptostegia grandiflora leaves (1 mg/ear
in 20 μL of vehicle) or Indomethacin (0.5 mg/ear in 20 μL
of vehicle), as reference drug. At the same time, the TPA
solution was applied to both faces of the right ear. The left
ear received only acetone, as a control. Four hours after
the inflammation induction, animals were sacrificed by cer-
vical dislocation and a disk (6 mm diameter) was removed
from both ears (treated and untreated) and individually
weighed on an Ohaus Pioneer™ (PA214) analytical balance.
The degree of edema was indicated by the increase
in the weight of the right ear disk over the left. The anti-
inflammatory activity was expressed as percentage of the
inhibition of edema in treated groups in comparison to
control group (vehicle) [10].
Histopathologic analysis was performed according to
standard protocols [31]. Ear samples were preserved in
buffered formalin, embedded in paraffin, cut into 5 μm
sections, and stained with hematoxylin eosin. Subse-
quently, ear tissue was analyzed by a blinded pathologist
using light microscopy, which assessed the presence of
edema, epidermal hyperplasia/hypertrophy, hyperkeratosis,
infiltration of mononuclear and polymorphonuclear cells,
connective tissue disruption, and dermal fibrosis, using
a scale of 0 to 4 (0, none; 1, mild; 2, mild; 3; moderate;
4, severe).
Myeloperoxidase (MPO) assay
MPO activity was measured according to the method by
[32]. Ear tissue was weighed and homogenized in 10 vol
of 50 mM PBS, pH 7.4. The homogenate was centrifuged
at 4000 rpm for 30 min at 4°C. The pellet was again ho-
mogenized in 10 vol of 50 mM PBS, pH 6.0, containing
0.5% HETAB. The homogenate was subjected to cycles
of freezing/thawing and brief periods of sonication (15 s)
and centrifugation at 4000 rpm for 10 min at 4°C. Super-
natants (20 μL) were mixed with 50 μL of o-dianisidine
dihydrochloride (0.067%) and 50 μL of hydrogen peroxide
(0.003%) in each well of a 96-well microplate, and incu-
bated for 5 min. Enzyme activity was determined by meas-
uring changes in the Optical Density at 450 nm (OD450),
using a microplate reader (Multiscan EX Thermo®), and
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calculated against the absorbance presented by the control
group.
Cell culture
The murine RAW 264.7 macrophage-like cell line was
obtained from the American Type Culture Collection
(TIB-71; Rockville, MD, USA) and routinely cultured in
DMEM supplemented with 2 mM L-glutamine, antibi-
otics (100 IU/mL of penicillin-100 μg/mL streptomycin)
and heat-inactivated FBS at 37°C in a humidified atmos-
phere containing 5% CO2.
MTT assay
The mitochondrial-dependent reduction of MTT to for-
mazan was used to assess the possible cytotoxic effects
of Cryptostegia grandiflora leaves on RAW 264.7 cells
[33,34]. Macrophages (2×105 cells/mL) were cultured at
37°C and allowed to grow to confluence. Subsequently,
the culture medium was replaced with various concen-
trations of test extracts/fractions or 1400 W for 30 min,
followed by stimulation with of E. coli LPS (1 μg/mL).
Control group was incubated with the same amount of
DMSO. Triton X-100 (2%) was used as positive control.
After 24 h, the medium was removed and cells incu-
bated with MTT solution (3 mg/mL). Four hours later
medium was carefully aspirated, formazan crystals were
dissolved in DMSO, and OD550 was measured using a
microplate reader (Multiscan EX Thermo®).
NO• and PGE2 production
The evaluation of the anti-inflammatory activity was per-
formed in a manner similar to that described for cell via-
bility. In brief, RAW 264.7 cells (2×105 cells/mL) were
allowed to grow to confluence at 37°C. The adherent
cells were treated for 30 min with various concentrations
of fractions from Cryptostegia grandiflora leaves, 1400
W or Rofecoxib, and stimulated with LPS (1 μg/mL).
Control cells were cultured under the same conditions
but were not exposed to the effect of LPS. Twenty four
hours later, culture supernatants were collected and stored
at −20°C until use.
NO• release was determined spectrophotometrically by
the accumulation of nitrite (NO2
−), using the Griess reac-
tion [35]. Briefly, 100 μL of cell culture medium was
mixed with 100 μL of Griess reagent (1:1 mixture of
0.1% N-(1-naphthyl) ethylenediamine dihydrochloride
and 1% sulfanilamide in 5% H3PO4), and incubated at
room temperature for 5 min. The OD550 of the samples
was measured using a microplate reader (Multiscan EX
Thermo®) and compared with a standard curve prepared
with NaNO2 (1–200 μM). Levels of PGE2 were deter-
mined using commercially available competitive ELISA
kits (R&D Systems, Minneapolis, MN) according to themanufacturer’s instructions. Final results were expressed
as pg/mL of supernatant.NO radical scavenging effect
NO-scavenging effect of fractions of Cryptostegia grandi-
flora leaves was determined by the method of [36] with
some modfications. Sodium nitroprusside (SNP) in
aqueous solution spontaneously generates NO• which in-
teracts with oxygen to produce NO2
− ions that can be esti-
mated using Griess reagent. Scavengers of NO• compete
with oxygen, leading to reduced production of NO2
− [37].
Briefly, SNP (5 mM) in PBS, pH 7.4, was mixed with test
compounds and incubated at 25°C for 120 min. After this
period, samples were incubated with an equal volume of
Griess reagent for 5 min. The OD550 was measured using a
microplate reader (Multiscan EX Thermo®) and compared
with standard solutions of NaNO2 (1–200 μM).DPPH radical scavenging activity
DPPH-scavenging effect was determined using the method
described by [38], with some modifications. In brief, 75 μL
of fractions from Cryptostegia grandiflora and ascorbic acid,
at various concentrations, were plated into 96-well plates,
mixed with 150 μL of DPPH (100 μg/mL; in methanol),
and incubated at room temperature (25 ± 3°C). Vehicles
were used as negative controls. After 30 min, the disappear-
ance of DPPH radical absorption was determined at OD550
using a microplate reader (Multiscan EX Thermo®).ABTS radical scavenging activity
ABTS-scavenging effect was determined using the method
described by [39], whit modifications. Briefly, 10 μL of vari-
ous concentrations of fractions from Cryptostegia grandi-
flora or ascorbic acid, used as positive controls, were
mixed with 190 μL of ABTS (3.5 mM; in ethanol) and
K2S2O8 (1.25 mM). The mixture was incubated at room
temperature for 5 min. After this time, the disappearance
of ABTS radical absorption was determined at OD405 using
a microplate reader (Multiscan EX Thermo®).Statistical analysis
Results from three independent assays were expressed as
mean ± standard error of the mean (S.E.M) and analyzed
using one-way analysis of variance (ANOVA), followed
by Dunnett’s or Tukey’s post hoc test, to determine the
differences between groups. Values of p < 0.05 were con-
sidered significant. LC50 and IC50 values were calculated
using non-linear regression analysis and expressed as the
mean and its 95% confidence interval.
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